Table of Content

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
What’s New in This Report
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials

Chapter 2 Summary and Highlights
Highlights of the Market for Nanomedicine

Chapter 3 Market Overview
Definition
Applications
Drug Delivery
Drugs and Therapy
In Vivo Imaging
In Vitro Diagnostics
Biomaterials
Active Implants
Overview
Medical Nanotechnology: Nanomedicine
Nanotechnology
Nanotechnology Uses
Medical Applications
Environmental Applications
Military Applications
Cosmetics
Nanotechnology Tools
Risks of Nanotechnology
Nanotechnology in the Marketplace
Development of Nanomedical Technologies
Liposomes
Dendrimers
Nanocrystals
Micelles
Fullerenes
Polymeric Nanoparticles
Nanoparticle-Drug Conjugates
Ligand-Targeted Nanoparticles
Ceramic Nanoparticles
Virosome Nanoparticles
Therapeutic Uses of Nanomedicine
Cancer Diagnostics and Therapy
Drug Delivery
Future Trends and Research Possibilities
Non-Invasive Nanodevices
Extracellular Devices
Intracellular Devices
Nanomachines to Control Tissue Healing
Eliminating Viruses
Correcting Chemistry
New Organs and Limbs
Fundamental Nanotechnology Research
U.S.
Europe
Japan
Risk Factors

Chapter 4 Impact of COVID-19 Pandemic
Introduction
Outbreak
Impact of COVID-19 on Nanomedicine

Chapter 5 Markets for Nanomedicine
Market Drivers
Market Estimates and Forecasts
Global Nanomedicine Market
Main Product Categories
Market Analysis by Clinical Application

Chapter 6 Global Nanomedicine Market Breakdown by Region
Introduction
North America
United States
Canada
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
Rest of the World (RoW)

Chapter 7 Competitive Landscape
Global Company Share Analysis
Mergers and Acquisitions
Agreements, Collaborations, Product Launches and Partnerships

Chapter 8 Company Profiles
ABBOTT
ABRAXIS BIOSCIENCE (CELGENE {BRISTOL MYERS SQUIBB})
APHIOS CORP.
BIOFORCE NANOSCIENCES HOLDINGS INC.
C SIXTY INC. (ARROWHEAD PHARMACEUTICALS)
ELAN (ALKERMES)
EYEPOINT PHARMACEUTICALS INC. (FORMERLY PSIVIDA LTD.)
FARFIELD SCIENTIFIC (BIOLIN SCIENTIFIC AB)
KLEINDIEK NANOTECHNIK GMBH
LIPLASOME PHARMA APS
MAGFORCE NANOTECHNOLOGIES
MICROFLUIDICS CORP.
NANOBIO CORP. (BLUEWILLOW BIOLOGICS)
NANOBIOTIX SA
NANOCARRIER CO. LTD.
NANOCOPOEIA, LLC.
NANOLOGIX INC.
NANOMIX INC.
NANOSPECTRA BIOSCIENCES INC.
NANOSTRUCTURES INC.
ORTHOVITA INC. (STRYKER CORP.)
PFIZER INC.
SANOFI S.A.
STARPHARMA
TECANGROUP LTD.
TRANSGENEX NANOBIOTECH INC.



List of Figures


Summary Figure A : Global Market for Nanomedicine, by Type, 2019-2026
Summary Figure B : Global Market for Nanopharmaceuticals, by Therapeutic Area, 2019-2026
Figure 1 : Global Market Share for Nanomedicine, by Region, 2020
Figure 2 : Abbott: Annual Revenue, 2018-2020
Figure 3 : Abbott: Revenue Share, by Country, 2020
Figure 4 : Abbott: Revenue Share, by Business Segment, 2020
Figure 5 : Bristol Myers Squibb: Annual Revenue, 2018-2020
Figure 6 : Bristol Myers Squibb: Revenue Share, by Region, 2020
Figure 7 : Alkermes: Annual Revenue, 2018-2020
Figure 8 : Stryker Corp.: Annual Revenue, 2018-2020
Figure 9 : Stryker Corp.: Revenue Share, by Region, 2020
Figure 10 : Stryker Corp.: Revenue Share, by Business Segment, 2020

List of Tables


Summary Table A : Global Market for Nanomedicine, by Type, Through 2026
Summary Table B : Global Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 1 : Nanomedicine Timescale
Table 2 : Main Nanotechnologies Used in Medicine, with Applications
Table 3 : Marketed Liposome Nanopharmaceuticals
Table 4 : Nanocrystal Pharmaceuticals
Table 5 : Marketed and Developmental Products in Micelle Form
Table 6 : Marketed Products with Nano-Enhanced Delivery
Table 7 : European Nanocenters
Table 8 : Marketed Nanopharmaceuticals
Table 9 : Global Nanomedicine Market, by Type, Through 2026
Table 10 : Global Nanopharmaceuticals Market, by Therapeutic Area, Through 2026
Table 11 : Major Marketed Anticancer Nanopharmaceuticals
Table 12 : Major Marketed CNS Nanopharmaceuticals
Table 13 : Major Marketed Anti-Infective Nanopharmaceuticals
Table 14 : Major Marketed Nanomedicines for Cardiovascular and Inflammatory Diseases
Table 15 : Global Market for Nanomedicine, by Region, Through 2026
Table 16 : North American Market for Nanomedicine, by Type, Through 2026
Table 17 : North American Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 18 : European Market for Nanomedicine, by Type, Through 2026
Table 19 : European Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 20 : Asia-Pacific Market for Nanomedicine, by Type, Through 2026
Table 21 : Asia-Pacific Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 22 : RoW Market for Nanomedicine, by Type, Through 2026
Table 23 : RoW Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 24 : Global Nanomedicine Market Ranking, by Company, 2020